Doiron, Bruno

School of Medicine
Medicine
(210) 567-0767
doiron@uthscsa.edu

In the past decade, I have made my career in research enabling me to better understand glucose metabolism at the physiological, cellular and molecular level. I have three discoveries to my credit in the field of gene regulation induced by glucose. I developed applications based on my basic research in diabetes and cancer. In diabetes, I used the gene therapy to secrete insulin in response to glucose. In cancer, I took advantage of the high glycolytic activity of tumors to develop a new drug. In addition to my scientific research, I have experience in the biotechnology sector. I was the initiator and founder of Biotechnology Company in Paris, France. I work as CEO for two year in my company. Recently at the UTHSCSA, I discovered a new protein expression in the pancreatic beta cells implicated in the mechanism of insulin release and which can be implicated in the development and proliferation of the beta cells and Im study gene regulation by glucose. I have excellent scientific skills as well as multiple disciplines, finding myself in the prefect position to study scientific questions at physiological, metabolism and molecular levels. As a fonder and CEO of biotechnology previously, I understand the product development and the market to make translated applications of fundamental research efficiently.